Preferred Label : indinavir;
MeSH definition : A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.;
CISMeF synonym : 157810-81-6 (Indinavir sulfate);
MeSH hyponym : L-735 524; MK-639; Indinavir Sulfate; crixivan; MK 639; MK639; L 735 524; L735 524; L-735,524; L 735,524; L735,524; Sulfate, Indinavir; Indinavir, Sulfate (1:1);
MeSH Related Number : indinavir sulfate; 150378-17-9 (Indinavir); 157810-81-6 (sulfate (1:1) (salt)); 771H53976Q;
Registry Number MeSH : 150378-17-9;
Related CAS MeSH : 771H53976Q (Indinavir sulfate);
Wikipedia link : https://en.wikipedia.org/wiki/Indinavir;
Is substance : O;
UNII : 5W6YA9PKKH;
InChIKey : XTYSXGHMTNTKFH-BDEHJDMKSA-N;
Origin ID : D019469;
UMLS CUI : C0376637;
ATC code(s)
Allowable qualifiers
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- CH05-10 [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
http://www.has-sante.fr/portail/jcms/c_2656376/fr/crixivan
2016
true
France
French
Indinavir Sulfate
indinavir
administration, oral
hiv protease inhibitors
indinavir
insurance, health, reimbursement
drug therapy, combination
adult
hiv infections
HIV-1
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/crixivan_18012012_avis_ct8307.pdf
http://www.has-sante.fr/portail/jcms/c_400703/crixivan-100-mg-gelule-180-gelules-code-cip-356-593-2-crixivan-200-mg-gelule-360-gelules-code-cip-342-099-0-crixivan-400-mg-gelule-90-gelules-code-cip-342-100-9-crixivan-400-mg-gelule-180-gelules-code-cip-342-101-5
http://www.has-sante.fr/portail/jcms/c_399369/crixivan-100-mg-gelules-180
http://www.has-sante.fr/portail/jcms/c_399241/crixivan-100-mg-gelules-boite-de-180
http://www.has-sante.fr/portail/jcms/c_1198165/crixivan
2012
France
French
indinavir
administration, oral
hiv protease inhibitors
indinavir
insurance, health, reimbursement
drug therapy, combination
adult
adolescent
child
hiv infections
HIV-1
indinavir
hiv protease inhibitors
urolithiasis
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/Crixivan
2012
United Kingdom
English
French
syndication feed
Contraindications, Procedure
indinavir
hiv protease inhibitors
acquired immunodeficiency syndrome
indinavir
indinavir
hiv protease inhibitors
hiv protease inhibitors
hiv infections
treatment outcome
HIV-1
adult
child
adolescent
drug therapy, combination
indinavir
summary of product characteristics
package leaflet
drug evaluation
Contraindications, Drug
---
http://www.meddispar.fr/medicaments/3420990
2008
France
French
capsules
administration, oral
drug prescriptions
indinavir
legislation, drug
indinavir
drug information
---
http://www.meddispar.fr/medicaments/3421015
2008
France
French
capsules
indinavir
administration, oral
drug prescriptions
legislation, drug
indinavir
drug information
---
http://www.meddispar.fr/medicaments/3421009
2008
France
French
capsules
indinavir
administration, oral
drug prescriptions
legislation, drug
indinavir
drug information
---
http://www.worldgastroenterology.org/UserFiles/file/guidelines/needlestick-french-2007.pdf
2007
true
Germany
French
English
Spanish
Portuguese
Russian
algorithms
needlestick injuries
occupational exposure
risk factors
needlestick injuries
blood-borne pathogens
security measures
chemoprevention
hepatitis B
hepatitis C
acquired immunodeficiency syndrome
hiv infections
indinavir
indinavir
hiv protease inhibitors
hiv protease inhibitors
lamivudine
lamivudine
anti-hiv agents
anti-hiv agents
zidovudine
zidovudine
child
adult
occupational exposure
practice guideline
---